Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10437800rdf:typepubmed:Citationlld:pubmed
pubmed-article:10437800lifeskim:mentionsumls-concept:C0016960lld:lifeskim
pubmed-article:10437800lifeskim:mentionsumls-concept:C0038727lld:lifeskim
pubmed-article:10437800lifeskim:mentionsumls-concept:C0079189lld:lifeskim
pubmed-article:10437800lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:10437800lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:10437800lifeskim:mentionsumls-concept:C1709634lld:lifeskim
pubmed-article:10437800pubmed:issue3lld:pubmed
pubmed-article:10437800pubmed:dateCreated1999-8-16lld:pubmed
pubmed-article:10437800pubmed:abstractTextEffects of sulfatide and its precursor galactosylceramide (gal-cer) on the kinetics of production of cytokines were studied. In human mononuclear leucocytes, gal-cer but not sulfatide induced significantly increased amounts of interleukin (IL)-1beta, IL-6 and tumor necrosis factor (TNF) mRNA. In phytohemagglutinin-stimulated cultures, gal-cer increased the levels of IL-1beta and IL-6 mRNA and secreted IL-1beta and IL-6, while sulfatide decreased the amounts of IL-6 mRNA and secreted IL-6. Gal-cer also increased TNF secretion. In lipopolysaccharide-stimulated cells, sulfatide but not gal-cer decreased the secretion of IL-1beta and IL-10, a potent suppressor of production of many cytokines. Thus, sulfatide and gal-cer affect cytokine production differently, most likely at the level of gene expression. This may have implications in diseases where inflammatory cytokines play a pathogenic role.lld:pubmed
pubmed-article:10437800pubmed:languageenglld:pubmed
pubmed-article:10437800pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10437800pubmed:citationSubsetIMlld:pubmed
pubmed-article:10437800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10437800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10437800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10437800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10437800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10437800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10437800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10437800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10437800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10437800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10437800pubmed:statusMEDLINElld:pubmed
pubmed-article:10437800pubmed:monthJullld:pubmed
pubmed-article:10437800pubmed:issn0014-5793lld:pubmed
pubmed-article:10437800pubmed:authorpubmed-author:BendtzenKKlld:pubmed
pubmed-article:10437800pubmed:authorpubmed-author:BuschardKKlld:pubmed
pubmed-article:10437800pubmed:authorpubmed-author:MånssonJ EJElld:pubmed
pubmed-article:10437800pubmed:authorpubmed-author:FredmanPPlld:pubmed
pubmed-article:10437800pubmed:authorpubmed-author:BovinL FLFlld:pubmed
pubmed-article:10437800pubmed:issnTypePrintlld:pubmed
pubmed-article:10437800pubmed:day23lld:pubmed
pubmed-article:10437800pubmed:volume455lld:pubmed
pubmed-article:10437800pubmed:ownerNLMlld:pubmed
pubmed-article:10437800pubmed:authorsCompleteYlld:pubmed
pubmed-article:10437800pubmed:pagination339-43lld:pubmed
pubmed-article:10437800pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10437800pubmed:meshHeadingpubmed-meshheading:10437800...lld:pubmed
pubmed-article:10437800pubmed:meshHeadingpubmed-meshheading:10437800...lld:pubmed
pubmed-article:10437800pubmed:meshHeadingpubmed-meshheading:10437800...lld:pubmed
pubmed-article:10437800pubmed:meshHeadingpubmed-meshheading:10437800...lld:pubmed
pubmed-article:10437800pubmed:meshHeadingpubmed-meshheading:10437800...lld:pubmed
pubmed-article:10437800pubmed:meshHeadingpubmed-meshheading:10437800...lld:pubmed
pubmed-article:10437800pubmed:meshHeadingpubmed-meshheading:10437800...lld:pubmed
pubmed-article:10437800pubmed:meshHeadingpubmed-meshheading:10437800...lld:pubmed
pubmed-article:10437800pubmed:meshHeadingpubmed-meshheading:10437800...lld:pubmed
pubmed-article:10437800pubmed:meshHeadingpubmed-meshheading:10437800...lld:pubmed
pubmed-article:10437800pubmed:meshHeadingpubmed-meshheading:10437800...lld:pubmed
pubmed-article:10437800pubmed:meshHeadingpubmed-meshheading:10437800...lld:pubmed
pubmed-article:10437800pubmed:meshHeadingpubmed-meshheading:10437800...lld:pubmed
pubmed-article:10437800pubmed:year1999lld:pubmed
pubmed-article:10437800pubmed:articleTitleIn vitro production of cytokines is influenced by sulfatide and its precursor galactosylceramide.lld:pubmed
pubmed-article:10437800pubmed:affiliationInstitute for Inflammation Research, H:S Rigshospitalet National University Hospital, Copenhagen, Denmark. bovin@post7.tele.dklld:pubmed
pubmed-article:10437800pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10437800pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:10437800pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10437800lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10437800lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10437800lld:pubmed